+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

Cystic Fibrosis (CF) Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Cystic Fibrosis (CF) Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • January 2022
  • 111 Pages
  • Global
From
Endothelin Receptor Antagonist Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Endothelin Receptor Antagonist Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • August 2024
  • 96 Pages
  • Global
From
Immuno-Oncology - Thematic Intelligence - Product Thumbnail Image

Immuno-Oncology - Thematic Intelligence

  • Report
  • May 2023
  • 169 Pages
  • Global
From
Ureter Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Ureter Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 150 Pages
  • Global
From
Cryptococcal Meningitis - Pipeline Insight, 2024 - Product Thumbnail Image

Cryptococcal Meningitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Fallopian Tube Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Fallopian Tube Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 871 Pages
  • Global
From
Red Biotechnology - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Red Biotechnology - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 115 Pages
  • Global
From
HIV: First-in-Class Therapies Target Major Unmet Needs Including Drug Resistance and Latency Reversal - Product Thumbnail Image

HIV: First-in-Class Therapies Target Major Unmet Needs Including Drug Resistance and Latency Reversal

  • Report
  • December 2019
  • 63 Pages
  • Global
From
Vaginal Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Vaginal Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 475 Pages
  • Global
From
Neoantigen Cancer Vaccine Market by Product, Technology, Delivery Mechanism, Neoantigen Type, Route of Administration, Application - Global Forecast 2025-2030 - Product Thumbnail Image

Neoantigen Cancer Vaccine Market by Product, Technology, Delivery Mechanism, Neoantigen Type, Route of Administration, Application - Global Forecast 2025-2030

  • Report
  • October 2024
  • 180 Pages
  • Global
From
T-Cell therapy Market Size, Share & Industry Trends Analysis Report By End User (Hospitals and Cancer Treatment Centers), By Indication (Lymphoma, Acute Lymphocytic Leukemia and Others), By Therapy Type, By Regional Outlook and Forecast, 2023 - 2030 - Product Thumbnail Image

T-Cell therapy Market Size, Share & Industry Trends Analysis Report By End User (Hospitals and Cancer Treatment Centers), By Indication (Lymphoma, Acute Lymphocytic Leukemia and Others), By Therapy Type, By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • June 2023
  • 263 Pages
  • Global
From
Engineered T Cells Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F - Product Thumbnail Image

Engineered T Cells Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F

  • Report
  • October 2023
  • 190 Pages
  • Global
From
Cell Culture Global Market Report 2024 - Product Thumbnail Image

Cell Culture Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Biotechnology Services Global Market Report 2024 - Product Thumbnail Image

Biotechnology Services Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Red Biotechnology Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028 - Product Thumbnail Image

Red Biotechnology Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028

  • Report
  • July 2023
  • 78 Pages
  • Global
From
Biotech Ingredient Global Market Report 2024 - Product Thumbnail Image

Biotech Ingredient Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Smart Life Sciences Manufacturing Global Market Report 2024 - Product Thumbnail Image

Smart Life Sciences Manufacturing Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Lyophilization Equipment and Services Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028) - Product Thumbnail Image

Lyophilization Equipment and Services Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

  • Report
  • April 2023
  • 114 Pages
  • Global
From
Cell Therapy Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Cell Therapy Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • August 2022
  • 115 Pages
  • Global
From
Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides & Customization. 2023 to 2027 - Product Thumbnail Image

Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides & Customization. 2023 to 2027

  • Report
  • November 2024
  • 449 Pages
  • Global
From
Loading Indicator